[1–4] While the recently published PRISMS study failed to show benefits with the use of r-tPA in patients with mild stroke, [6] it did not achieve its desired recruitment and the majority of patients enrolled had subcortical lacunar strokes. This evidence concerns the gene PLAT and Stroke.